RxDoctor Payments Data

Helmuth Billy, MD

General Surgery · Zephyr Cove, NVNPI 1447317664

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Teleflex LLC at 28.6% of the total. 2025 is the largest year on record at $119,041, 4.9 times the $24,301 reported in 2019.

$493,180in general payments, 2019–2025

Across 695 payments — averaging $709.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$141K
  • Medtronic$101K
  • Lexington Medical, Inc.$76K
  • Intuitive Surgical$67K
  • Covidien LP$36K
  • Suture Ease, Inc.$24K
  • plus $47K from 31 others
$55,782in research payments, 2019–2025

Across 10 payments — averaging $5578.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Lexington Medical, Inc.$56K

What the payments were for

  • Consulting fees$162,46133%
  • Speaking & faculty fees$236,00848%
  • Travel & lodging$39,8208%
  • Food & beverage$31,5046%
  • Education$16,3493%
  • Entertainment$3760%
  • Other$6,6621%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few general surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$169,448
Medicare patients
186
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine117$899
Omeprazole46$674
Ondansetron OdtOndansetron31$261
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$182
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$147
Pantoprazole Sodium14$72
Ondansetron Hcl12$46

Paid to pharmacies, not to this prescriber.

Other general surgery in Zephyr Cove

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →